EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology

Himmat Singh Chawra, Mohit Agarwal, Anurag Mishra, Shailendra Singh Chandel, Ravindra Pal Singh, Gaurav Dubey, Neelima Kukreti, Mithilesh Singh

Pathology - Research and Practice · 2024-02 · 254 · 155091

DOI: 10.1016/j.prp.2024.155091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024-02. Verfasst von Himmat Singh Chawra und 7 weiteren Autor:innen. Beteiligte Einrichtung: NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 190 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNA-21 (miR-21) was recognized as a key figure in the intricate web of tumor biology, with a prominent role in regulating the PTEN tumor suppressor gene and the PI3K/AKT cascade. This review elucidates the multifaceted interactions between miR-21, PTEN, and the PI3K/AKT signaling, shedding light on their profound implications in cancer initiation, progression, and therapeutic strategies. The core of this review delves into the mechanical intricacies of miR-21-mediated PTEN suppression and its consequent impact on PI3K/AKT pathway activation. It explores how miR-21, as an oncogenic miRNA, targets PTEN directly or indirectly, resulting in uncontrolled activation of PI3K/AKT, fostering cancerous cell survival, proliferation, and evasion of apoptosis. Furthermore, the abstract emphasizes the clinical relevance of these molecular interactions, discussing their implications in various cancer types, prognostic significance, and potential as therapeutic targets. The review provides insights into ongoing research efforts to develop miR-21 inhibitors and strategies to restore PTEN function, offering new avenues for cancer treatment. This article illuminates the critical function of miR-21 in PTEN suppression and PI3K/AKT activation, offering profound insights into its implications for cancer biology and the potential for targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsNeoplasmsHumansProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesSignal TransductionPTEN PhosphohydrolaseApoptosisCell ProliferationBiologyCell Line, Tumor

Stichwörter der Autor:innen

CancerEpigeneticsMicroRNA-21PI3K/AKTPTEN

Substanzen

MicroRNAsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPTEN PhosphohydrolasePTEN protein, humanMIRN21 microRNA, human

Autor:innen und Institutionen

  • NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India.
  • School of Pharmacy, Graphic Era Hill University, Dehradun 248007, India.
  • NIMS Institute of Pharmacy, NIMS University Rajasthan, Jaipur, India. Electronic address: mithilesh.singh@nimsuniversity.org.

Zitieren

APA

Chawra, H. S., Agarwal, M., Mishra, A., Chandel, S. S., Singh, R. P., Dubey, G., Kukreti, N., & Singh, M. (2024). MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology. Pathology - Research and Practice, 254, 155091. https://doi.org/10.1016/j.prp.2024.155091

Vancouver

Chawra HS, Agarwal M, Mishra A, Chandel SS, Singh RP, Dubey G, et al. MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology. Pathology - Research and Practice. 2024;254:155091. doi:10.1016/j.prp.2024.155091

BibTeX
@article{Chawra2024,
  author = {Chawra, Himmat Singh and Agarwal, Mohit and Mishra, Anurag and Chandel, Shailendra Singh and Singh, Ravindra Pal and Dubey, Gaurav and Kukreti, Neelima and Singh, Mithilesh},
  title = {MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology},
  journal = {Pathology - Research and Practice},
  year = {2024},
  volume = {254},
  pages = {155091},
  doi = {10.1016/j.prp.2024.155091}
}
Kostenlos starten →